Illumina and PacBio Sequencing of Human and Mouse DNA and RNA

Organization

Department of Health (HC)

Closes

December 3, 2026 at 2:00 p.m.

Category

services

Notice type

Request for Proposal

Delivery

Chile; South Korea; United States of America; Peru; Honduras; Canada; Europe; Panama; Colombia

Estimated value

Not stated

Reference

1000273702

Trade agreements

Canada-Panama Free Trade Agreement, Canada-Colombia Free Trade Agreement, Canada-Korea Free Trade Agreement (CKFTA), Canada-Peru Free Trade Agreement (CPFTA), Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), Canada-UK Trade Continuity Agreement (Canada-UK TCA), Canadian Free Trade Agreement (CFTA), Canada-Ukraine Free Trade Agreement (CUFTA), World Trade Organization Agreement on Government Procurement (WTO GPA), Canada-Honduras Free Trade Agreement, Canada-European Union Comprehensive Economic and Trade Agreement (CETA), Canada-Chile Free Trade Agreement (CCFTA)

Closing time as published by the source; time zone assumed: America/Toronto.

The Mechanistic Studies Division (MSD) of Health Canada’s Environmental Health Research and Science Bureau investigates the pathways by which physical, chemical and microbiological agents can cause adverse health effects. To determine how chemical substances cause DNA damage that can lead to illnesses like cancer or inherited diseases, MSD requires high-throughput genome sequencing services utilizing Illumina and Pacific Biosciences (PacBio) platforms. The primary objective of this contract is to secure long-term high-quality sequencing services for pre-prepared DNA libraries and genomic DNA and/or RNA utilizing Illumina or PacBio Revio platforms for the full duration of projects funded until up to 2030-2031. This requirement encompasses the sequencing of multiple mouse and human error-corrected next-generation sequencing (ecNGS) DNA libraries, genomic DNA and/or RNA samples in direct support of four distinct research projects. These projects are distributed across the Division and funded through three separate programs. Collectively, they employ advanced genomic technologies to support public health protection by identifying environmental mutagens, evaluating occupational hazards, and improving toxicological testing methodologies. Specifically, this work will use ecNGS, whole-genome sequencing (WGS), whole-exome sequencing and/or RNA-sequencing approaches to detect and characterize both spontaneous mutations and mutations induced by chemical and environmental exposures in mouse and human DNA as well as gene expression changes. The resulting data will contribute to a better understanding of mutagenic mechanisms, exposure-related genetic damage, and the development of more sensitive and informative approaches for genetic toxicology and human health risk assessment.

Source

CanadaBuys (Government of Canada) · Open Government Licence – Canada

View the original notice ↗

Notice details come from the public source named here; 3ENET republishes them under the source licence and links to the original, which is authoritative.

Last updated: November 12, 2026 at 1:15 a.m.

Find out if this tender fits you

Create a free 3ENET account to save it, see why it matches your capabilities, and find people to bid with.